Publications by authors named "S Caimmi"
Purpose: A multidisciplinary approach to Inflammatory Bowel Disease (IBD) has recently demonstrated a positive impact in pediatric patients, reducing dropout rates and facilitating the transition to adult care. Our study aims to evaluate how this approach influences disease activity, dropout rates, and transition.
Methods: We conducted a longitudinal observational study including all patients diagnosed with IBD during pediatric-adolescent age, with a minimum follow-up period of 12 months.
Drug hypersensitivity reactions are common in children. Risk factors predisposing to IgE-mediated drug allergies and delayed drug reactions are a matter of debate. Gender, age, previous reactions to the same drug or to another drug, reduced drug metabolism, chronic diseases, polypharmacy, drug doses are linked with the onset of hypersensitivity reactions in some children.
View Article and Find Full Text PDFArticle Synopsis
- * A study conducted at a pediatric clinic analyzed data from children hospitalized for iGAS infections in 2023, revealing clinical patterns and groundbreaking insights into the infections.
- * Between 2016 and 2023, the number of GAS infections remained relatively stable, but 2023 saw a significant increase in pediatric cases, with common symptoms including high fever, tachycardia, and vomiting; specific lab results were also noted.
Article Synopsis
- The study investigates the diagnostic delay experienced by pediatric patients with celiac disease across 13 referral centers in Italy, covering cases from 2010 to 2019 and analyzing data in 2023.
- It finds that the median diagnostic delay for these patients is about 5 months, with a notable portion experiencing extreme delays of 11 months or more.
- Factors such as age at diagnosis influence delays, with younger patients (under 3 years) generally facing shorter wait times for diagnosis.
Drug-induced anaphylaxis in children is less common than in adults and primarily involves beta-lactams and nonsteroidal anti-inflammatory drugs. Epidemiological studies show variable prevalence, influenced by age, gender, and atopic diseases. The pathophysiology includes IgE-mediated reactions and non-IgE mechanisms, like cytokine release reactions.
View Article and Find Full Text PDF